Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Intellia Therapeutics
Intellia Therapeutics
Intellia doses first patient as hereditary angioedema gene editing therapy lands in clinic
Fierce Biotech
Mon, 12/13/21 - 11:46 pm
Intellia Therapeutics
HAE
clinical trials
NTLA-2002
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Fierce Biotech
Mon, 10/25/21 - 11:53 pm
Intellia Therapeutics
LogicBio Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
Intellia looks to eye diseases in latest deal
BioPharma Dive
Wed, 10/13/21 - 10:38 pm
Intellia Therapeutics
gene editing
eye disease
Jennifer Doudna Reacts to Intellia CRISPR Breakthrough, Outlines Challenges
BioSpace
Fri, 07/2/21 - 11:01 am
Jennifer Doudna
CRISPR
Intellia Therapeutics
3 Biotech Stocks With Big Catalysts in June
Motley Fool
Tue, 06/22/21 - 10:55 am
Corbus Pharmaceuticals
lenabasum
clinical trials
Gemini Therapeutics
age-related macular degeneration
Intellia Therapeutics
hATTR-pn
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intellia announced a new tool for gene editing. Academics said they rewrote history
Endpoints
Tue, 03/30/21 - 10:16 pm
CRISPR
gene editing
Intellia Therapeutics
Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
BioPharma Dive
Wed, 11/11/20 - 11:03 pm
Intellia Therapeutics
CRISPR
gene editing
Gates Foundation
Intellia Aims Big with CRISPR Therapy to Cure ATTR
BioSpace
Tue, 10/20/20 - 10:44 am
Intellia Therapeutics
CRISPR
hereditary ATTR amyloidosis
NTLA-2001
Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Mon, 06/1/20 - 10:30 am
Regeneron
Intellia Therapeutics
hemophilia A
hemophilia B
CRISPR
drug development
Here's Why CRISPR Stocks Fell in January
Motley Fool
Wed, 02/5/20 - 10:07 am
Intellia Therapeutics
CRISPR Therapeutics
Editas Medicine
CRISPR
More CRISPR Stock Catalysts Ahead
Motley Fool
Mon, 11/25/19 - 09:38 am
gene editing
CRISPR
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
Here's Why CRISPR Stocks Fell as Much as 40.7% in October
Motley Fool
Tue, 11/6/18 - 12:25 am
CRISPR
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Intellia Therapeutics, Inc. Stock History: The Story of a CRISPR Gene Editing Pioneer
Motley Fool
Sun, 07/29/18 - 10:49 am
Intellia Therapeutics
gene editing
CRISPR
Here's Why CRISPR Stocks Are Down as Much as 11.4% Today
Motley Fool
Tue, 07/24/18 - 11:43 pm
CRISPR
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic
Motley Fool
Wed, 06/13/18 - 09:45 am
CRISPR
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Here's Why the Top CRISPR Stocks Rose as Much as 47.1% in May
Motley Fool
Fri, 06/8/18 - 11:59 pm
CRISPR
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
Intellia Therapeutics Announces WT1 for treating Acute Myeloid Leukemia as Its First Cell Therapy Target
Thu, 05/17/18 - 09:41 am
Intellia Therapeutics
acute myeloid leukemia
CRISPR Focused Intellia Therapeutics Adds Scientific Advisors in Immuno-Oncology and Autoimmunity
CP Wire
Mon, 05/14/18 - 10:56 am
Intellia Therapeutics
CRISPR
CRISPR Focused Intellia Therapeutics Adds Scientific Advisors in Immuno-Oncology and Autoimmunity
Mon, 05/14/18 - 10:03 am
Intellia Therapeutics
CRISPR
Pages
« first
‹ previous
1
2
3
next ›
last »